Mecasermin

Results: 20



#Item
11ALS/PLS COSMOS Newsletter Vo l u m e 2 , I s s u e 2 Summer 2012 A Message from the Principal Investigator Hiroshi Mitsumoto, MD, DSc We just came back from the annual Investigators’ and Coordinators’ Meeting at the

ALS/PLS COSMOS Newsletter Vo l u m e 2 , I s s u e 2 Summer 2012 A Message from the Principal Investigator Hiroshi Mitsumoto, MD, DSc We just came back from the annual Investigators’ and Coordinators’ Meeting at the

Add to Reading List

Source URL: www.columbiaals.org

Language: English - Date: 2014-09-12 04:41:04
12PRIOR AUTHORIZATION POLICY Increlex® (mecasermin [rDNA origin] injection Tercica)  TO INITIATE A COVERAGE REVIEW, CALL[removed]

PRIOR AUTHORIZATION POLICY Increlex® (mecasermin [rDNA origin] injection Tercica) TO INITIATE A COVERAGE REVIEW, CALL[removed]

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2013-10-03 14:59:14
13ALS COSMOS Newsletter Spring 2010 In Progress.qxp

ALS COSMOS Newsletter Spring 2010 In Progress.qxp

Add to Reading List

Source URL: www.columbiaals.org

Language: English - Date: 2014-09-11 04:41:10
14Peptide hormones / Biology / Growth hormone deficiency / Growth hormone treatment / Growth hormone / Insulin-like growth factor 1 / Mecasermin rinfabate / Growth hormones / Endocrine system / Medicine

GH.18 Form # 10710 R:12.13 State of Maine Department of Health & Human Services MaineCare/MEDEL Prior Authorization Form

Add to Reading List

Source URL: www.mainecarepdl.org

Language: English - Date: 2014-01-16 11:57:16
15Amyotrophic Lateral Sclerosis. 2009; 10: 248250  REPORT ALSUntangled Update 1: Investigating a bug (Lyme Disease) and a drug (Iplex) on behalf of people with ALS

Amyotrophic Lateral Sclerosis. 2009; 10: 248250 REPORT ALSUntangled Update 1: Investigating a bug (Lyme Disease) and a drug (Iplex) on behalf of people with ALS

Add to Reading List

Source URL: www.aldf.com

Language: English - Date: 2011-04-04 10:52:12
16HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INCRELEX® safely and effectively. See full prescribing information for INCRELEX®. INCRELEX® (mecasermin [rDNA ori

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INCRELEX® safely and effectively. See full prescribing information for INCRELEX®. INCRELEX® (mecasermin [rDNA ori

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-03-04 08:08:08
17HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INCRELEX® safely and effectively. See full prescribing information for INCRELEX®. INCRELEX® (mecasermin [rDNA ori

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INCRELEX® safely and effectively. See full prescribing information for INCRELEX®. INCRELEX® (mecasermin [rDNA ori

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-06-04 14:49:22
18CrossMark_Color_flat+click

CrossMark_Color_flat+click

Add to Reading List

Source URL: web.mit.edu

Language: English - Date: 2014-07-11 11:37:41
19CLINICAL TRIAL 2010 No

CLINICAL TRIAL 2010 No

Add to Reading List

Source URL: www.hkl.gov.my

Language: English - Date: 2011-11-01 12:02:21
20Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy

Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English